Aarti Pharmalabs
Ticker >

Aarti Pharmalabs share price

Aarti Pharmalabs Ltd.

NSE: AARTIPHARM BSE: 543748 SECTOR: Pharmaceuticals & Drugs  35k   77   17

502.30
-2.45 (-0.49%)
NSE: Today, 11:54 AM

Price Summary

Today's High

₹ 510.3

Today's Low

₹ 497.3

52 Week High

₹ 566.95

52 Week Low

₹ 320.3

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 4552.14 Cr.

Enterprise Value

₹ 4745.68 Cr.

No. of Shares

9.06 Cr.

P/E

25.63

P/B

2.89

Face Value

₹ 5

Div. Yield

0.39 %

Book Value (TTM)

₹  173.98

CASH

₹ 13.18 Cr.

DEBT

₹ 206.71 Cr.

Promoter Holding

46.46 %

EPS (TTM)

₹  19.6

Sales Growth

60.6%

ROE

12.83 %

ROCE

15.6%

Profit Growth

60.9 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year60.6%
3 Year∞%
5 YearNA

Profit Growth

1 Year60.9%
3 Year1995.19%
5 YearNA

ROE%

1 Year12.83%
3 Year9.35%

ROCE %

1 Year15.6%
3 Year10.57%

Debt/Equity

0.1437

Price to Cash Flow

19.91

Interest Cover Ratio

12.3895795202187

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 46.46 0
Dec 2023 46.46 0
Sep 2023 46.3 0
Jun 2023 45.98 0
Mar 2023 45.98 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 1995.18895669986% for the Past 3 years.
  • The company has significantly decreased its debt by 117.9115 Cr.
  • Company has a healthy Interest coverage ratio of 12.3895795202187.
  • Company has a healthy liquidity position with current ratio of 2.10619514896026.

 Limitations

  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 374.27 358.14 356.14 373.03
Total Expenditure 297.47 281.4 282.34 284.75
Operating Profit 76.8 76.74 73.8 88.28
Other Income 0 4.86 0 0.2
Interest 5.8 4.03 3.82 4.1
Depreciation 14.25 15.44 16.32 16.94
Exceptional Items 0 0 0 0
Profit Before Tax 56.75 62.13 53.66 67.44
Tax 16.75 14.5 11.85 19.25
Profit After Tax 40 47.63 41.81 48.19
Adjusted EPS (Rs) 4.41 5.26 4.61 5.32

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 0 0 941.02 1511.25
Total Expenditure 0.02 0 761.24 1202.91
Operating Profit -0.02 0 179.79 308.34
Other Income 0 0 2.51 1.28
Interest 0 0 11.34 20.49
Depreciation 0 0 37.23 55.77
Exceptional Items 0 0 0 0
Profit Before Tax -0.02 0 133.73 233.36
Tax 0 0 27 61.63
Net Profit -0.02 0 106.73 171.73
Adjusted EPS (Rs.) -0.75 -0.18 4269.05 18.95

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 0.25 0.25 0.25 45.31
Total Reserves -0.02 -0.02 1284.03 1393.27
Borrowings 0 0 0 0
Other N/C liabilities 0.02 0 60.88 69.38
Current liabilities 0 0.02 481.67 455.31
Total Liabilities 0.25 0.25 1826.83 1963.27
Assets
Net Block 0 0 701.12 848.4
Capital WIP 0 0 165.23 62.23
Intangible WIP 0 0 22.14 39.67
Investments 0 0 39.87 42.67
Loans & Advances 0 0 8.21 11.33
Other N/C Assets 0 0 0 0
Current Assets 0.25 0.25 890.27 958.98
Total Assets 0.25 0.25 1826.83 1963.27
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -0.02 0 133.73 233.36
Adjustment 0 0 46.08 75.37
Changes in Assets & Liabilities 0 0 -229.65 -23.3
Tax Paid 0 0 -15 -56.73
Operating Cash Flow -0.02 0 -64.84 228.69
Investing Cash Flow 0 0 -133.54 -115.55
Financing Cash Flow 0.27 0 254.63 -156.53
Net Cash Flow 0.25 0 56.25 -43.39

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 45.98 45.98 46.30 46.46 46.46
aarnav rashesh gogri 0.61 0.61 0.61 0.61 0.61
aashay rashesh gogri 0.61 0.61 0.61 0.61 0.61
aashyav business trust (a... - - 0.04 0.04 0.04
alchemie financial servic... 0.74 0.74 0.74 0.74 0.74
alchemie finserv pvt. ltd... 0.29 0.29 0.29 0.29 0.29
anushakti enterprise priv... 3.19 3.19 3.28 3.28 3.28
arti rajendra gogri 0.52 0.52 0.52 0.52 0.52
bhanu pradip savla 0.17 0.17 0.17 0.17 0.17
bhavna family private tru... 0.89 0.89 0.89 0.89 0.89
bhavna shah lalka 0.57 0.57 0.57 0.57 0.57
chandrakant vallabhaji go... 0.17 0.17 0.17 0.17 0.17
dilesh roadlines pvt ltd 0.01 0.01 0.01 0.01 0.01
gogri finserv pvt. ltd. 0.29 0.29 0.37 0.37 0.37
gunavanti navin shah 0.10 0.10 0.10 0.10 0.10
heena bhatia 0.36 0.36 0.36 0.36 0.36
heena family private trus... 0.92 0.92 0.92 0.92 0.92
hetal gogri gala 2.89 2.89 2.89 2.89 2.89
indira madan dedhia 0.20 0.20 0.20 0.20 0.20
jasmine family trust (rel... 0.76 0.76 0.76 0.76 0.76
jaya chandrakant gogri 2.70 2.70 2.81 2.97 2.97
jayesh shah 0.02 0.02 0.02 0.02 0.02
labdhi business trust (sa... 3.14 3.14 3.14 3.14 3.14
lotus family trust (gloir... 0.69 0.69 0.69 0.69 0.69
mananjay singh garewal 0.18 0.18 0.18 0.18 0.18
manisha rashesh gogri 0.61 0.61 0.61 0.61 0.61
manomaya business trust (... 1.44 1.44 1.44 1.44 1.44
mirik rajendra gogri 3.08 3.08 3.08 3.08 3.08
monisha bhatia 0.13 0.13 0.13 0.13 0.13
nehal garewal 1.24 1.24 1.24 1.24 1.24
nikhil holdings private l... 0.20 0.20 0.20 0.20 0.20
nikhil parimal desai 0.85 0.85 0.85 0.85 0.85
orchid family trust (rela... 1.82 1.82 1.82 1.82 1.82
parimal hasmukhlal desai 0.44 0.44 0.44 0.44 0.44
rajendra vallabhaji gogri... 1.57 1.57 1.57 1.57 1.57
rajendra vallabhaji gogri... - 0.34 0.34 0.34 0.34
rashesh chandrakant gogri... 4.23 4.23 4.23 4.23 4.23
ratanben premji gogri 0.37 0.37 0.37 0.37 0.37
renil rajendra gogri 3.08 3.08 3.08 3.08 3.08
safechem enterprises priv... 1.61 1.61 1.61 1.61 1.61
sarla shantilal shah 2.69 2.69 2.69 2.69 2.69
shantilal tejshi shah (hu... - - - 0.31 0.31
shreya suneja 0.12 0.12 0.12 0.12 0.12
tulip family trust (gloir... 1.82 1.82 1.82 1.82 1.82
valiant organics limited 0.01 0.01 0.01 0.01 0.01
shantilal tejshi shah (hu... - 0.31 0.31 - -
rajendra vallabhaji gogri... 0.34 - - - -
shantilal tejshi shah huf... 0.31 - - - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 54.02 54.02 53.70 53.54 53.54
aditya birla sun life tru... 2.11 1.36 1.26 1.05 1.05
baron emerging markets fu... 1.13 1.10 1.10 1.08 1.01
investor education and pr... 0.35 0.35 0.35 0.35 0.35
life insurance corporatio... 6.80 6.80 6.80 6.80 6.26
llp 0.32 0.29 0.30 0.28 0.28
morgan stanley investment... 1.12 1.12 1.04 1.06 1.08
nishant pradip shah - - - - 1.10
ntasain discovery master ... - - 2.01 1.94 2.04
hdfc trustee company ltd ... 2.03 - - - -

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

Company Presentations

  • ConcallQ3FY24 15 Feb 2024
  • PresentationQ4FY23 30 Jun 2023
  • PresentationQ3FY24 12 Feb 2024
  • PresentationQ1FY24 19 Sep 2023

Aarti Pharmalabs Stock Price Analysis and Quick Research Report. Is Aarti Pharmalabs an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Aarti Pharmalabs and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Aarti Pharmalabs cash from the operating activity was Rs 228.6894 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Aarti Pharmalabs has a Debt to Equity ratio of 0.1437 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Aarti Pharmalabs , the EPS growth was -99.5561305471384 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Aarti Pharmalabs has OPM of 20.4026897508139 % which is a good sign for profitability.
     
  • ROE: Aarti Pharmalabs have a average ROE of 12.8272017934664 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Aarti Pharmalabs is Rs 502.2. One can use valuation calculators of ticker to know if Aarti Pharmalabs share price is undervalued or overvalued.
Last Updated on:
Brief about Aarti Pharmalabs

Aarti Pharmalabs Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Aarti Pharmalabs Ltd. is a leading manufacturer of pharmaceuticals and specialty chemicals in India. The company was founded in 1984 and has since grown to become a major player in its industry. Aarti Pharmalabs operates across various segments, including active pharmaceutical ingredients, specialty chemicals, and pharma intermediates. Its wide product portfolio and diverse customer base provide the company with a competitive edge in the industry.

Aarti Pharmalabs Ltd. Share Price

Aarti Pharmalabs Ltd.'s share price is one of the critical indicators of investor sentiment towards the company. On our stock analysis page, you can find the latest share price of Aarti Pharmalabs Ltd. along with historical price charts that provide insights into the company's financial performance over time. You can also use our pre-built screening tools to compare Aarti Pharmalabs's share price with that of other companies in the same sector.

Aarti Pharmalabs Ltd. Balance Sheet

Aarti Pharmalabs Ltd.'s balance sheet is an essential financial document that shows the company's assets, liabilities, and equity at a given point in time. On our stock analysis page, you can access Aarti Pharmalabs's latest annual and quarterly balance sheets along with premium features like DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools can help you ascertain the fair value of Aarti Pharmalabs's stock by analyzing various financial metrics such as earnings, assets, and liabilities.

Aarti Pharmalabs Ltd. Annual Report

Aarti Pharmalabs Ltd.'s annual report is a comprehensive document that provides insights into the company's financial performance, business strategy, and management outlook. On our stock analysis page, you can download Aarti Pharmalabs's latest annual reports and study its financial statements, auditor reports, and management discussion and analysis (MD&A) sections. This information can help investors make informed decisions about investing in Aarti Pharmalabs's stock.

Aarti Pharmalabs Ltd. Dividend

Aarti Pharmalabs Ltd.'s dividend payouts are an important metric to consider for long-term stock investors. On our stock analysis page, you can access Aarti Pharmalabs's latest dividend payout details, including the dividend yield, dividend history, and payout ratio. You can also compare Aarti Pharmalabs's dividend payouts with those of its peers using our pre-built screening tools.

Aarti Pharmalabs Ltd. Quarterly Result

Aarti Pharmalabs Ltd.'s quarterly results provide investors with timely updates on the company's financial performance. On our stock analysis page, you can find Aarti Pharmalabs's latest quarterly results, including its revenue, net profit, and earnings per share (EPS). You can also use our premium features like DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis to analyze Aarti Pharmalabs's financial performance and estimate its fair value.

Aarti Pharmalabs Ltd. Stock Price

Aarti Pharmalabs Ltd.'s stock price is a key metric that reflects the company's market valuation. On our stock analysis page, you can access Aarti Pharmalabs's latest stock price and track its performance over time using historical price charts. You can also use our pre-built screening tools to compare Aarti Pharmalabs's stock price with that of its peers in the same industry.

Aarti Pharmalabs Ltd. Price Chart

Aarti Pharmalabs Ltd.'s price chart provides investors with a visual representation of the company's stock performance over time. On our stock analysis page, you can find Aarti Pharmalabs's latest price chart along with historical charts that cover various time periods. You can also use our pre-built screening tools to compare Aarti Pharmalabs's price chart with that of other companies in the same industry.

Aarti Pharmalabs Ltd. News

Aarti Pharmalabs Ltd.'s news section provides investors with the latest updates on the company's business activities, financial performance, and strategic initiatives. On our stock analysis page, you can access Aarti Pharmalabs's latest news articles and press releases, as well as news from various other sources. Our pre-built screening tools also help you stay up-to-date with the latest news on Aarti Pharmalabs and other companies in the same sector.

Aarti Pharmalabs Ltd. Concall Transcripts

Aarti Pharmalabs Ltd.'s concall transcripts provide investors with insights into the company's management outlook and strategy. On our stock analysis page, you can access Aarti Pharmalabs's latest concall transcripts and study the discussion between the company's management and analysts. This information can help you make informed decisions about investing in Aarti Pharmalabs's stock.

Aarti Pharmalabs Ltd. Investor Presentations

Aarti Pharmalabs Ltd.'s investor presentations provide investors with an overview of the company's financial and business performance. On our stock analysis page, you can download Aarti Pharmalabs's latest investor presentations and study its financial metrics, business strategy, and management outlook. This information can help you assess the company's growth potential and make informed decisions about investing in its stock.

Aarti Pharmalabs Ltd. Promoters

Aarti Pharmalabs Ltd.'s promoters are the individuals or entities that hold a significant stake in the company and are responsible for its management and operations. On our stock analysis page, you can access information about Aarti Pharmalabs's promoters and their shareholding patterns. This information can help you assess the company's management quality and stability and make informed decisions about investing in its stock.

Aarti Pharmalabs Ltd. Shareholders

Aarti Pharmalabs Ltd.'s shareholders are the individuals or entities that hold a stake in the company through their investment in its stock. On our stock analysis page, you can access information about Aarti Pharmalabs's shareholders and their shareholding patterns. This information can help you assess the company's investor base and make informed decisions about investing in its stock.

Read More
X